Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review.

Drugs & Aging
Ronald L CastelinoTimothy F Chen

Abstract

A significant problem in older people (aged >or=65 years) is the use of potentially inappropriate medications (PIMs), including those with sedative and anticholinergic properties. However, effective intervention strategies have yet to be identified. The Drug Burden Index (DBI) is an evidence-based tool that measures a person's total exposure to medications with sedative and anticholinergic properties and has been shown to be independently associated with impairment in cognitive and physical function. The main aim of the study was to investigate whether Home Medicines Review (HMR) services by pharmacists for community-dwelling older people would lead to an improvement in the use of medications, as measured by a decrease in the DBI score. The study also aimed to investigate the (i) distribution of DBI scores and PIMs among older people living in the community, and (ii) impact of pharmacists' recommendations on DBI scores and PIMs. A retrospective analysis of medication reviews was performed for 372 community-dwelling older people (aged >or=65 years) who received an HMR service from the pharmacist. The main outcome measure was the total DBI score at baseline and post-HMR. The data were also examined to determine the extent of PIM ...Continue Reading

References

Mar 2, 1995·The New England Journal of Medicine·J M GuralnikR B Wallace
Sep 1, 1996·The American Journal of Emergency Medicine·R M GoldbergS Wong
Jan 1, 1999·Clinical Pharmacology and Therapeutics·J T HanlonH J Cohen
Aug 25, 1999·Drugs & Aging·A R Moore, S T O'Keeffe
Dec 28, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·M H ChinP D Friedmann
Feb 24, 2001·Journal of the American Geriatrics Society·J T HanlonM Weinberger
Nov 12, 2002·Clinics in Geriatric Medicine·Rebecca J Beyth, Ronald I Shorr
Jan 3, 2003·The New England Journal of Medicine·Mary E Tinetti
Dec 23, 2003·Journal of the American Geriatrics Society·Shelly L GrayAndrea Z LaCroix
Feb 11, 2004·Archives of Internal Medicine·Margie Rauch Goulding
Nov 18, 2004·The Annals of Pharmacotherapy·Harita R PatelLaura E Hall
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Bruce StuartNancy Friedley
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Joseph T HanlonShelly L Gray
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Gerda G FillenbaumKenneth E Schmader
Nov 26, 2004·British Journal of Clinical Pharmacology·Lene SorensenMichael S Roberts
Dec 21, 2004·British Journal of Clinical Pharmacology·L M WeekesS R Phillips
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Daniela FialováUNKNOWN AdHOC Project Research Group
Jul 28, 2005·The Annals of Pharmacotherapy·Kate M O'Dell, Suzan N Kucukarslan
Oct 28, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Kara A BottiggiFrederick A Schmitt
Dec 29, 2006·Clinical Pharmacology and Therapeutics·F LandiG Onder
Apr 25, 2007·Archives of Internal Medicine·Sarah N HilmerDarrell R Abernethy
Jun 8, 2007·European Journal of Clinical Pharmacology·Marie-Laure LarocheLouis Merle
Aug 19, 2007·Drugs & Aging·Nathalie van der VeldeTischa J M van der Cammen
Aug 24, 2007·Clinical Pharmacology and Therapeutics·Y-J CaoD R Abernethy
Jan 1, 2008·Research in Nursing & Health·Donna M FickJennifer L Waller
Jan 11, 2008·Drugs & Aging·Antoine ParienteAnnie Fourrier-Réglat
Aug 2, 2008·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Prasad S NishtalaTimothy F Chen
Nov 22, 2008·Drugs & Aging·Shoba IyerDavid G Le Couteur
Nov 28, 2008·Clinical Pharmacology and Therapeutics·S N Hilmer, D Gnjidic
May 28, 2009·The Annals of Pharmacotherapy·Ronald L CastelinoTimothy F Chen
Aug 8, 2009·British Journal of Clinical Pharmacology·Danijela GnjidicSarah N Hilmer

❮ Previous
Next ❯

Citations

Jun 8, 2012·International Journal of Clinical Pharmacy·Stephen R CarterTimothy F Chen
May 2, 2014·Annales pharmaceutiques françaises·E Jean-BartC Mouchoux
Aug 23, 2012·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Sahar KarimiPatricia W Slattum
Oct 19, 2011·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Rebecca L DunnToni L Ripley
Oct 23, 2014·International Journal of Environmental Research and Public Health·Maria Rubio-ValeraClaire L O'Reilly
Nov 26, 2011·Expert Review of Clinical Pharmacology·Arduino A Mangoni
Oct 13, 2015·Current Medical Research and Opinion·Patricia E McLarinRonald L Castelino
Sep 14, 2013·Journal of the American Pharmacists Association : JAPhA·Teri WestRuth Emptage
Apr 5, 2011·The American Journal of Geriatric Pharmacotherapy·Emily P PeronSteven M Handler
Feb 22, 2011·The American Journal of Geriatric Pharmacotherapy·Heidi T TaipaleJ Simon Bell
Jun 7, 2013·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Stephen R CarterTimothy F Chen
May 5, 2012·The International Journal of Pharmacy Practice·Benjamin J BasgerRebekah J Moles
Jul 11, 2012·The International Journal of Pharmacy Practice·Stephen R CarterLesley White
Aug 7, 2012·Journal of Clinical Pharmacy and Therapeutics·H F KwintM L Bouvy
Feb 17, 2015·Journal of Clinical Pharmacy and Therapeutics·A P A L SantosD P Lyra
Mar 28, 2013·Geriatrics & Gerontology International·Prasad S NishtalaJune M Tordoff
Feb 14, 2014·Australasian Journal on Ageing·Elizabeth ManiasAlexandra Smykowsky
Apr 8, 2016·Journal of the American Pharmacists Association : JAPhA·Rebecca J HanusJoseph A Zorek
Aug 8, 2015·Research in Social & Administrative Pharmacy : RSAP·Natali JokanovicJ Simon Bell
Jan 16, 2016·SAGE Open Medicine·Mohammed Saji Salahudeen, Prasad S Nishtala
Aug 31, 2010·Evaluation & the Health Professions·Ronald L CastelinoBeata V Bajorek
Jul 13, 2012·The Annals of Pharmacotherapy·Sukhpreet KaurMichael S Roberts
Sep 19, 2017·European Journal of Clinical Pharmacology·L M J SandersM J G van Heuvelen
Jul 5, 2018·Journal of the American Geriatrics Society·Sonja E KallioMarika K Pohjanoksa-Mäntylä
Jun 13, 2019·The Medical Journal of Australia·Amy PageDina C LoGiudice
Nov 11, 2019·Journal of General Internal Medicine·Ariel R GreenCynthia M Boyd
Mar 13, 2020·International Journal of Clinical Pharmacy·Petra CzarniakBruce Sunderland
Jun 27, 2019·British Journal of Clinical Pharmacology·V M SloeserwijN J de Wit
Jul 1, 2020·The International Journal of Pharmacy Practice·Patricia McCormickIan Bates

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.